{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:22Z","timestamp":1791920062474,"version":"4.3.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.pt.2003.09.002","type":"journal-article","created":{"date-parts":[[2003,10,11]],"date-time":"2003-10-11T04:49:49Z","timestamp":1065847789000},"page":"488-494","source":"Crossref","is-referenced-by-count":281,"title":["Chemotherapy of human African trypanosomiasis: current and future prospects"],"prefix":"10.1016","volume":"19","author":[{"given":"Alan H.","family":"Fairlamb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2003.09.002_BIB1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jama.281.4.361","article-title":"Access to essential drugs in poor countries: a lost battle?","volume":"281","author":"Pecoul","year":"1999","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.pt.2003.09.002_BIB2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nm0902-908b","article-title":"Resurrecting the resurrection drug","volume":"8","author":"Wickware","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.pt.2003.09.002_BIB3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","article-title":"The treatment of human African trypanosomiasis","volume":"33","author":"P\u00e9pin","year":"1994","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.pt.2003.09.002_BIB4","series-title":"Burger's Medicinal Chemistry and Drug Discovery: Chemotherapeutic Agents","first-page":"1033","article-title":"Antiprotozoal agents","author":"Fries","year":"2003"},{"key":"10.1016\/j.pt.2003.09.002_BIB5","first-page":"19","article-title":"The chemotherapy of onchocerciasis XVIII. Aspects of treatment with suramin","volume":"46","author":"Awadzi","year":"1995","journal-title":"Trop. Med. Parasitol."},{"issue":"Suppl. 1","key":"10.1016\/j.pt.2003.09.002_BIB6","first-page":"S8","article-title":"Intravesical suramin: a novel agent for the treatment of superficial transitional-cell carcinoma of the bladder","volume":"14","author":"Walther","year":"1996","journal-title":"World J. Urol."},{"issue":"Suppl. 1","key":"10.1016\/j.pt.2003.09.002_BIB7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/annonc\/8.suppl_1.S119","article-title":"New drugs in non-Hodgkin's lymphoma","volume":"8","author":"Arbuck","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.pt.2003.09.002_BIB8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1015666024386","article-title":"Suramin's development: what did we learn?","volume":"20","author":"Kaur","year":"2002","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.pt.2003.09.002_BIB9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0166-6851(80)90050-X","article-title":"Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo","volume":"1","author":"Fairlamb","year":"1980","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2003.09.002_BIB10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0001-706X(93)90096-T","article-title":"The uptake of the trypanocidal drug suramin in combination with low-density lipoproteins by Trypanosoma brucei and its possible mode of action","volume":"54","author":"Vansterkenburg","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2003.09.002_BIB11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0166-6851(02)00096-8","article-title":"Evidence for a non-LDL-mediated entry route for the trypanocidal drug suramin in Trypanosoma brucei","volume":"122","author":"Pal","year":"2002","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2003.09.002_BIB12","series-title":"Parasites: Molecular Biology, Drug and Vaccine Design","first-page":"233","article-title":"Unique properties of glycosomal enzymes","author":"Opperdoes","year":"1989"},{"key":"10.1016\/j.pt.2003.09.002_BIB13","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4269\/ajtmh.1984.33.1073","article-title":"New drug combination for experimental late-stage African trypanosomiasis: DL-\u03b1-difluoromethylornithine (DFMO) with suramin","volume":"33","author":"Clarkson","year":"1984","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2003.09.002_BIB14","series-title":"The African Trypanosomiases","first-page":"711","article-title":"Chemoprophylaxis of human trypanosomiasis","author":"Waddy","year":"1970"},{"key":"10.1016\/j.pt.2003.09.002_BIB15","doi-asserted-by":"crossref","first-page":"28153","DOI":"10.1074\/jbc.270.47.28153","article-title":"Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei","volume":"270","author":"Carter","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2003.09.002_BIB16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1124\/mol.59.3.586","article-title":"Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: Implications for cross-resistance with arsenicals","volume":"59","author":"De Koning","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pt.2003.09.002_BIB17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1073\/pnas.87.3.950","article-title":"Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs","volume":"87","author":"Shapiro","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2003.09.002_BIB18","doi-asserted-by":"crossref","first-page":"40174","DOI":"10.1074\/jbc.M008405200","article-title":"Inhibition of Trypanosoma brucei gene expression by RNA interference using an integratable vector with opposing T7 promoters","volume":"275","author":"Wang","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2003.09.002_BIB19","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1093\/nar\/gkf394","article-title":"Pentamidine inhibits catalytic activity of group I intron Ca.LSU by altering RNA folding","volume":"30","author":"Zhang","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pt.2003.09.002_BIB20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1550-7408.1994.tb05931.x","article-title":"Inhibition of in vitro splicing of a group I intron of Pneumocystis carinii","volume":"41","author":"Liu","year":"1994","journal-title":"J. Eukaryot. Microbiol."},{"key":"10.1016\/j.pt.2003.09.002_BIB21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0001-706X(93)90094-R","article-title":"Polyamine and pentamidine metabolism in African trypanosomes","volume":"54","author":"Berger","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2003.09.002_BIB22","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1074\/jbc.M110118200","article-title":"S-adenosylmethionine decarboxylase from Leishmania donovani \u2013 molecular, genetic, and biochemical characterization of null mutants and overproducers","volume":"277","author":"Roberts","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2003.09.002_BIB23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1042\/bj2960759","article-title":"A calmodulin-stimulated Ca2+ pump in plasma-membrane vesicles from Trypanosoma brucei: selective inhibition by pentamidine","volume":"296","author":"Benaim","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.pt.2003.09.002_BIB24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/bj2840463","article-title":"Ca2+ transport by digitonin-permeabilized Leishmania donovani. Effects of Ca2+, pentamidine and WR-6026 on mitochondrial membrane potential in situ","volume":"284","author":"Vercesi","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.pt.2003.09.002_BIB25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.micro.52.1.745","article-title":"Surface receptors and transporters of Trypanosoma brucei","volume":"52","author":"Borst","year":"1998","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.pt.2003.09.002_BIB26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0169-4758(99)01414-3","article-title":"The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes","volume":"15","author":"Barrett","year":"1999","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.pt.2003.09.002_BIB27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1471-4922(03)00069-2","article-title":"Pentamidine uptake and resistance in pathogenic protozoa: past, present and future","volume":"19","author":"Bray","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2003.09.002_BIB28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/361173a0","article-title":"Arsenical-resistant trypanosomes lack an unusual adenosine transporter","volume":"361","author":"Carter","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pt.2003.09.002_BIB29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0001-706X(01)00177-2","article-title":"Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter","volume":"80","author":"De Koning","year":"2001","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2003.09.002_BIB30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0166-6851(94)00215-9","article-title":"Characterization of pentamidine-resistant Trypanosoma brucei brucei","volume":"69","author":"Berger","year":"1995","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2003.09.002_BIB31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000239130","article-title":"Pharmacokinetic properties of the trypanocidal drug melarsoprol","volume":"39","author":"Burri","year":"1993","journal-title":"Chemotherapy"},{"key":"10.1016\/j.pt.2003.09.002_BIB32","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(00)02141-3","article-title":"Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial","volume":"355","author":"Burri","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2003.09.002_BIB33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s002800050998","article-title":"Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia","volume":"44","author":"Soignet","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.pt.2003.09.002_BIB34","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1067\/mcp.2000.105990","article-title":"Investigations of the metabolites of the trypanocidal drug melarsoprol","volume":"67","author":"Keiser","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pt.2003.09.002_BIB35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1432-1033.1987.tb13563.x","article-title":"Effects of various metabolic conditions and of the trivalent arsenical melarsen oxide on the intracellular levels of fructose 2,6-bisphosphate and of glycolytic intermediates in Trypanosoma brucei","volume":"166","author":"Van Schaftingen","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pt.2003.09.002_BIB36","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1073\/pnas.86.8.2607","article-title":"Trypanothione is the primary target for arsenical drugs against African trypanosomes","volume":"86","author":"Fairlamb","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2003.09.002_BIB37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1146\/annurev.mi.46.100192.003403","article-title":"Metabolism and functions of trypanothione in the Kinetoplastida","volume":"46","author":"Fairlamb","year":"1992","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.pt.2003.09.002_BIB38","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1046\/j.1365-2958.2002.02831.x","article-title":"Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei","volume":"43","author":"Shahi","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.pt.2003.09.002_BIB39","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1046\/j.1365-2958.2000.01721.x","article-title":"Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress","volume":"35","author":"Krieger","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.pt.2003.09.002_BIB40","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/bst0310415","article-title":"Polyamine biosynthetic enzymes as drug targets in parasitic protozoa","volume":"31","author":"Heby","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.pt.2003.09.002_BIB41","series-title":"Trypanosomiasis and Leishmaniasis: Biology and Control","first-page":"149","article-title":"Polyamine metabolism in trypanosomes","author":"Fairlamb","year":"1997"},{"key":"10.1016\/j.pt.2003.09.002_BIB42","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0001-706X(93)90093-Q","article-title":"Combination chemotherapy of CNS trypanosomiasis","volume":"54","author":"Jennings","year":"1993","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2003.09.002_BIB43","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-3156.2002.00933.x","article-title":"Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis","volume":"7","author":"Mpia","year":"2002","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2003.09.002_BIB44","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0166-6851(94)90011-6","article-title":"Relationship of global chloroquine transport and reversal of resistance in Plasmodium falciparum","volume":"63","author":"Bray","year":"1994","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.pt.2003.09.002_BIB45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(90)90106-W","article-title":"Sensitivity of parasites to free radical damage by antiparasitic drugs","volume":"73","author":"Docampo","year":"1990","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.pt.2003.09.002_BIB46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-4894(82)90099-6","article-title":"Trypanosoma rhodesiense: evaluation of the antitrypanosomal action of 2,5-bis(4-guanylphenyl)furan dihydrochloride","volume":"53","author":"Steck","year":"1982","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.pt.2003.09.002_BIB47","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1471-4922(00)01829-8","article-title":"New drugs for the treatment of human African trypanosomiasis: research and development","volume":"17","author":"Keiser","year":"2001","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2003.09.002_BIB48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2174\/1381612023396159","article-title":"Chemotherapy of human African trypanosomiasis","volume":"8","author":"Burchmore","year":"2002","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pt.2003.09.002_BIB49","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2174\/1568026023393048","article-title":"Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development","volume":"2","author":"Schmidt","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pt.2003.09.002_BIB50","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2174\/1381612013397564","article-title":"Trypanothione as a target in the design of antitrypanosomal and antileishmanial agents","volume":"7","author":"Augustyns","year":"2001","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pt.2003.09.002_BIB51","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/emboj\/21.7.1791","article-title":"TbMP81 is required for RNA editing in Trypanosoma brucei","volume":"21","author":"Drozdz","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.pt.2003.09.002_BIB52","doi-asserted-by":"crossref","first-page":"17075","DOI":"10.1074\/jbc.M210467200","article-title":"Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei \u2013 in vitro RNA interference and in vivo inhibition studies","volume":"278","author":"Montalvetti","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pt.2003.09.002_BIB53","doi-asserted-by":"crossref","first-page":"14177","DOI":"10.1073\/pnas.222454899","article-title":"Glucose is toxic to glycosome-deficient trypanosomes","volume":"99","author":"Furuya","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2003.09.002_BIB54","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1073\/pnas.092669999","article-title":"Galactose metabolism is essential for the African sleeping sickness parasite Trypanosoma brucei","volume":"99","author":"Roper","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pt.2003.09.002_BIB55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0966-842X(98)01433-4","article-title":"Recent advances in identifying and validating drug targets in trypanosomes and leishmanias","volume":"7","author":"Barrett","year":"1999","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.pt.2003.09.002_BIB56","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0968-0896(99)00008-5","article-title":"Cysteine protease inhibitors as chemotherapy for parasitic infections","volume":"7","author":"McKerrow","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pt.2003.09.002_BIB57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1359-6446(99)01451-8","article-title":"Computational methods for the prediction of \u2018drug-likeness\u2019","volume":"5","author":"Clark","year":"2000","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.pt.2003.09.002_BIB58","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1367-5931(99)80058-1","article-title":"Recognizing molecules with drug-like properties","volume":"3","author":"Walters","year":"1999","journal-title":"Curr. Opin. Chem. Biol."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492203002423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492203002423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,20]],"date-time":"2019-02-20T22:58:23Z","timestamp":1550703503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492203002423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S1471492203002423"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2003.09.002","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}